share_log

RIV Capital Reports YoY Increase In Q1 Revenue, Gross Profit Ahead Of Merger With Cansortium To Create Four-State Cannabis Company

RIV Capital Reports YoY Increase In Q1 Revenue, Gross Profit Ahead Of Merger With Cansortium To Create Four-State Cannabis Company

RIV Capital報告稱,在與Cansortium合併創建四州大麻公司之前,第一季度收入和毛利同比增長
Benzinga ·  05/31 11:30

Cannabis-focused acquisition and investment firm RIV Capital Inc. (CSE:RIV) (OTC:CNPOF) released its financial results on Thursday for the first quarter ended March 31, 2024.

專注於大麻的收購和投資公司RIV Capital Inc.(CSE: RIV)(場外交易代碼:CNPOF)週四公佈了截至2024年3月31日的第一季度財務業績。

Mike Totzke, the company's COO and interim CEO, called the first quarter "pivotal" referring to the official launch of the company's recreational cannabis operations in New York. The company opened its first adult-use dispensary in White Plains.

該公司首席運營官兼臨時首席執行官邁克·託茲克稱第一季度 “至關重要”,指的是該公司在紐約正式啓動休閒大麻業務。該公司在懷特普萊恩斯開設了第一家成人用藥房。

"Following years of hard work, we are incredibly proud of our entire team for their dedication, which enabled us to take this transformative step forward," Totzke said. "The growth we have seen at our newly launched White Plains dispensary is well in line with our expectations and customer feedback has been fantastic."

託茲克說:“經過多年的努力,我們爲整個團隊的奉獻精神感到非常自豪,這使我們能夠向前邁出這一變革性的一步。”“我們在新推出的懷特普萊恩斯藥房看到的增長完全符合我們的預期,客戶反饋也非常好。”

The first quarter earnings announcement comes on the heels of the announced merger of RIV Capital and Cansortium Inc., a multi-state cannabis operator under the FLUENT brand. The combined company will operate in Florida, New York, Texas, and Pennsylvania, covering 25% of the U.S. population with eight cultivation and processing facilities and 42 retail dispensaries.

第一季度業績是在宣佈將RIV Capital與FLUENT品牌旗下的多州大麻運營商Cansortium Inc. 合併之後發佈的。合併後的公司將在佛羅里達州、紐約州、德克薩斯州和賓夕法尼亞州開展業務,擁有八個種植和加工設施以及42個零售藥房,覆蓋美國人口的25%。

See also: Revenue Growth And Cannabis Market Expansion: RIV Capital's Fiscal Highlights For 2023

另見:收入增長和大麻市場擴張:RIV Capital的2023年財政亮點

As yet another earnings reporting season wraps up it is important to understand what these figures mean for the future of the industry. Hear directly for top executives, investors and policymakers at the 19th Benzinga Cannabis Capital Conference, coming to Chicago this Oct. 8-9. Get your tickets now before prices surge by following this link.

隨着又一個業績期的結束,重要的是要了解這些數字對該行業的未來意味着什麼。在將於10月8日至9日在芝加哥舉行的第19屆Benzinga大麻資本會議上,直接聽取高層管理人員、投資者和決策者的意見。點擊此鏈接,立即在價格飆升之前獲取門票。

Q1 2024 Financial Highlights

2024 年第一季度財務摘要

  • Net revenue was $2.1 million, compared to $1.7 million for the same period of 2023.
  • Gross profit was $613 000, up from $212 000 in the first quarter of last year.
  • The cost of goods sold was $1.9 million, compared to $1.6 million for the first quarter of last year.
  • Selling, general, and administrative expenses were $6.2 million for the period, compared to $5.3 million in the prior year's period.
  • Operating loss was $5.6 million, up from $5.1 million in the corresponding period of 2023.
  • Net loss was roughly $5 million, down from $23.6 million in the first quarter of the prior year.
  • 淨收入爲210萬美元,而2023年同期爲170萬美元。
  • 毛利爲61.3萬美元,高於去年第一季度的21.2萬美元。
  • 商品銷售成本爲190萬美元,而去年第一季度爲160萬美元。
  • 該期間的銷售、一般和管理費用爲620萬美元,而去年同期爲530萬美元。
  • 營業虧損爲560萬美元,高於2023年同期的510萬美元。
  • 淨虧損約爲500萬美元,低於去年第一季度的2360萬美元。

CNPOF Price Action

CNPOF 價格走勢

RIV Capital's shares traded 3.9738% higher at $0.1347 per share at the time of writing on Friday morning.

在週五上午撰寫本文時,RIV Capital的股價上漲3.9738%,至每股0.1347美元。

Related News

相關新聞

  • RIV Capital Reports YoY Revenue Growth In Q2, Plans To Establish Dominant Role In New York Wholesale Market
  • RIV Capital Q4 FY23 Revenue Declines 10.5% Hit By Illicit Market And Statewide Decline In Medical Cannabis Sales
  • Riv Capital Stock Trading Higher On Stagnating Q3 FY23 Revenue And CEO Departing
  • RIV Capital報告第二季度收入同比增長,計劃在紐約批發市場佔據主導地位
  • RIV Capital 2023財年第四季度收入下降10.5%,受非法市場和全州醫用大麻銷售下降的影響
  • 由於2013財年第三季度收入停滯不前,首席執行官離職,Riv Capital股票走高
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論